Skip to content
OpenCapital
Get started

4D Molecular Therapeutics FDMT Cash ratio

Cash ratio at other companies

Eli Lilly logo
Eli LillyLLY
0.1×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.6×-0.3×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
1.4×+0.2×
EyePoint, Inc. logo
EyePoint, Inc. EYPT
2.1×0.0×
AbbVie logo
AbbVieABBV
0.2×+0.1×
Regenxbio logo
RegenxbioRGNX
0.2×-1.0×

Other financials

Income statement

See full
Revenue$3.0M+21,664%
Operating income-$73.6M-37.3%
Net income-$68.8M-43.3%
EPS (diluted)-$1.01-17.4%

Balance sheet

See full
Cash & equivalents$72.5M-45.7%
Total debt$20.5M-13.9%
Total equity$451.8M-3.8%
Total assets$512.9M-0.5%

Cash flow

See full
Operating cash flow-$68.1M-42.6%
CapEx--100%
Free cash flow-$68.1M-40.8%

Valuation

See full
Market cap$602.22M+215%
Enterprise value$550.27M+574%
P/S6.8×-8,306×

Profitability

See full
Operating margin-220.1%-110pp
Net margin-174,314.2%-62,763pp
FCF margin-154,209.2%-53,057pp

Returns & leverage

See full
Return on equity-45.4%+29.8pp
Debt / equity0×0.0×
Current ratio9.3×-3.0×

Where this comes from

Calculated from 4D Molecular Therapeutics’s reported figures.

cash and equivalents/total current liabilities=1.7×

Based on the most recent quarter.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 4D Molecular Therapeutics's cash ratio?
4D Molecular Therapeutics (FDMT) reported cash ratio of 1.7× in Q1 2026.
How has 4D Molecular Therapeutics's cash ratio changed year-over-year?
4D Molecular Therapeutics's cash ratio decreased by 66.4% year-over-year, from 5× to 1.7×.
What is the long-term trend for 4D Molecular Therapeutics's cash ratio?
Over 5 years (2020 to 2025), 4D Molecular Therapeutics's cash ratio has grown at a -39.2% compound annual growth rate (CAGR), from 16.5× to 1.4×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.